Tonic BCR signaling presents in the GCB DLBCL subtype, which is mechanistically distinct from chronic active BCR signaling since it does not engage BTK, CARD11, or NF-κB [159]. The gene discussed is NFKB1; the disease is diffuse large B-cell lymphoma.